TY - JOUR
T1 - Automated quantification of nonperfusion areas in 3 vascular plexuses with optical coherence tomography angiography in eyes of patients with diabetes
AU - Hwang, Thomas S.
AU - Hagag, Ahmed M.
AU - Wang, Jie
AU - Zhang, Miao
AU - Smith, Andrew
AU - Wilson, David J.
AU - Huang, David
AU - Jia, Yali
N1 - Funding Information:
This work was supported by grants R01 EY027833, DP3 DK104397, R01 EY024544, and P30 EY010572 from the National Institutes of Health, an unrestricted departmental funding grant and William & Mary Greve Special Scholar Award from Research to Prevent Blindness, New York, New York.
Funding Information:
Funding/Support: This work was supported by grants R01 EY027833, DP3 DK104397, R01 EY024544, and P30 EY010572 from the National Institutes of Health, an unrestricted departmental funding grant and William & Mary Greve Special Scholar Award from Research to Prevent Blindness, New York, New York.
Publisher Copyright:
© 2018 American Medical Association. All rights reserved.
PY - 2018/8
Y1 - 2018/8
N2 - IMPORTANCE: Diabetic retinopathy (DR) is a leading cause of vision loss that is managed primarily through qualitative clinical examination of the retina. Optical coherence tomography angiography (OCTA) may offer an objective and quantitative method of evaluating DR. OBJECTIVE: To quantify capillary nonperfusion in 3 vascular plexuses in the macula of eyes patients with diabetes of various retinopathy severity using projection-resolved OCTA (PR-OCTA). DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study at a tertiary academic center comprising 1 eye each from healthy control individuals and patients with diabetes at different severity stages of retinopathy. Data were acquired and analyzed between January 2015 and December 2017. MAIN OUTCOMES AND MEASURES Foveal avascular zone area, extrafoveal avascular area (EAA), and the sensitivity of detecting levels of retinopathy. RESULTS: The study included 39 control individuals (20 women [51%]; mean [SD] age, 43.41 [19.37] years); 16 patients with diabetes without retinopathy (8 women [50%]; mean [SD] age, 56.50 [12.43] years); 23 patients with mild to moderate nonproliferative DR (18 women [78%]; mean [SD] age, 62.48 [10.55] years); and 32 patients with severe nonproliferative DR or proliferative DR (12 women [38%]; mean age, 53.41 [14.05] years). Mean (SD) foveal avascular zone area was 0.203 (0.103) mm 2 for control individuals, 0.192 (0.084) mm 2 for patients with diabetes without retinopathy, 0.243 [0.079] mm 2 for mild to moderate nonproliferative DR, and 0.359 (0.275) mm 2 for severe nonproliferative DR or proliferative DR. Mean (SD) EAA in whole inner retinal slab in these groups, respectively, were 0.020 (0.031) mm 2 , 0.034 (0.047) mm 2 , 0.038 (0.040) mm 2 , and 0.237 (0.235) mm 2 . The mean (SD) sum of EAA from 3 segmented plexuses in each of the respective groups were 0.103 (0.169) mm 2 , 0.213 (0.242) mm 2 , 0.451 (0.243) mm 2 , and 1.325 (1.140) mm 2 . With specificity fixed at 95%, using EAA in inner retinal slab, the sensitivity of detecting patients with diabetes from healthy control individuals was 28% (95% CI, 18%-40%), 31% for patients with DR (95% CI, 19%-45%), and 47% for patients with severe DR (95% CI, 29%-65%) from whole inner retinal EAA. With the sum of EAA from 3 individual plexuses, the sensitivities were 69% (95% CI, 57%-80%), 82% (95% CI, 70%-91%), and 97% (95% CI, 85%-100%), respectively. Avascular areas were not associated with signal strength index. The commercial vessel density from the 2-plexus scheme distinguished the groups with lower sensitivity and were dependent on SSI. CONCLUSIONS AND RELEVANCE: Automatically quantified avascular areas from a 3-layer segmentation scheme using PR-OCTA distinguished levels of retinopathy with a greater sensitivity than avascular areas from unsegmented inner retinal slab or measurements from a commercially available vessel density in 2-layer scheme. Additional studies are needed to investigate the applicability of nonperfusion parameters in clinical settings.
AB - IMPORTANCE: Diabetic retinopathy (DR) is a leading cause of vision loss that is managed primarily through qualitative clinical examination of the retina. Optical coherence tomography angiography (OCTA) may offer an objective and quantitative method of evaluating DR. OBJECTIVE: To quantify capillary nonperfusion in 3 vascular plexuses in the macula of eyes patients with diabetes of various retinopathy severity using projection-resolved OCTA (PR-OCTA). DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional study at a tertiary academic center comprising 1 eye each from healthy control individuals and patients with diabetes at different severity stages of retinopathy. Data were acquired and analyzed between January 2015 and December 2017. MAIN OUTCOMES AND MEASURES Foveal avascular zone area, extrafoveal avascular area (EAA), and the sensitivity of detecting levels of retinopathy. RESULTS: The study included 39 control individuals (20 women [51%]; mean [SD] age, 43.41 [19.37] years); 16 patients with diabetes without retinopathy (8 women [50%]; mean [SD] age, 56.50 [12.43] years); 23 patients with mild to moderate nonproliferative DR (18 women [78%]; mean [SD] age, 62.48 [10.55] years); and 32 patients with severe nonproliferative DR or proliferative DR (12 women [38%]; mean age, 53.41 [14.05] years). Mean (SD) foveal avascular zone area was 0.203 (0.103) mm 2 for control individuals, 0.192 (0.084) mm 2 for patients with diabetes without retinopathy, 0.243 [0.079] mm 2 for mild to moderate nonproliferative DR, and 0.359 (0.275) mm 2 for severe nonproliferative DR or proliferative DR. Mean (SD) EAA in whole inner retinal slab in these groups, respectively, were 0.020 (0.031) mm 2 , 0.034 (0.047) mm 2 , 0.038 (0.040) mm 2 , and 0.237 (0.235) mm 2 . The mean (SD) sum of EAA from 3 segmented plexuses in each of the respective groups were 0.103 (0.169) mm 2 , 0.213 (0.242) mm 2 , 0.451 (0.243) mm 2 , and 1.325 (1.140) mm 2 . With specificity fixed at 95%, using EAA in inner retinal slab, the sensitivity of detecting patients with diabetes from healthy control individuals was 28% (95% CI, 18%-40%), 31% for patients with DR (95% CI, 19%-45%), and 47% for patients with severe DR (95% CI, 29%-65%) from whole inner retinal EAA. With the sum of EAA from 3 individual plexuses, the sensitivities were 69% (95% CI, 57%-80%), 82% (95% CI, 70%-91%), and 97% (95% CI, 85%-100%), respectively. Avascular areas were not associated with signal strength index. The commercial vessel density from the 2-plexus scheme distinguished the groups with lower sensitivity and were dependent on SSI. CONCLUSIONS AND RELEVANCE: Automatically quantified avascular areas from a 3-layer segmentation scheme using PR-OCTA distinguished levels of retinopathy with a greater sensitivity than avascular areas from unsegmented inner retinal slab or measurements from a commercially available vessel density in 2-layer scheme. Additional studies are needed to investigate the applicability of nonperfusion parameters in clinical settings.
UR - http://www.scopus.com/inward/record.url?scp=85051340846&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85051340846&partnerID=8YFLogxK
U2 - 10.1001/jamaophthalmol.2018.2257
DO - 10.1001/jamaophthalmol.2018.2257
M3 - Article
C2 - 29902297
AN - SCOPUS:85051340846
SN - 2168-6165
VL - 136
SP - 929
EP - 936
JO - JAMA Ophthalmology
JF - JAMA Ophthalmology
IS - 8
ER -